1 results match your criteria: "California 91301 (work completed while at Washington University). jwelch@a2biotherapeutics.com.[Affiliation]"
Molecular responses in decitabine- and decitabine/ venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromes.
Haematologica
August 2024
Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110; A2 Biotherapeutics, Agoura Hills, California 91301 (work completed while at Washington University).